Business Segments Telix Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. Other stock markets 07:12:56 12/06/2026 BST			5-day change	1st Jan Change
13.60 ^AUD	+0.97%		+2.18%	+21.43%

06-03	Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration; Shares Down 3%	MT
06-02	Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration	MT

Breakdown by Business Segment (AUD)

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Biological Products
Precision Medicine	-	-	-	771M	622M
Total Assets	-	-	-	480M	233M
Gross Profit	-	-	-	500M	399M
EBITDA	-	-	-	259M	216M
D&A	-	-	-	5.57M	3.33M
Operating Income	-	-	-	245M	210M
Manufacturing Solutions	-	-	-	2.75M	245M
Total Assets	-	-	-	222M	515M
Gross Profit	-	-	-	42K	22.25M
EBITDA	-	-	-	-23.87M	-21.72M
D&A	-	-	-	1.29M	16.93M
Operating Income	-	-	-	-25.04M	-23.94M
Therapeutics	-	-	-	9.35M	9.27M
Total Assets	-	-	-	216M	228M
Gross Profit	-	-	-	9.35M	9.04M
EBITDA	-	-	-	-73.46M	-98M
D&A	-	-	-	-	278K
Operating Income	-	-	-	-73.46M	-98.25M
Product Development	-	3.73M	5.5M	-	-
Total Assets	-	44.28M	46.74M	-	-
EBT	-	-76.6M	-123M	-	-
Gross Profit	-	-	5.5M	-	-
EBITDA	-	-76.03M	-122M	-	-
D&A	-	578K	538K	-	-
Operating Income	-	-	-123M	-	-
Net Income	-	-76.6M	-123M	-	-
Commercial	-	156M	497M	-	-
Total Assets	-	112M	288M	-	-
Income Tax Expense	-	5.71M	-	-	-
EBT	-	34.19M	217M	-	-
Gross Profit	-	-	309M	-	-
EBITDA	-	39.62M	224M	-	-
D&A	-	4.61M	5.66M	-	-
Operating Income	-	-	217M	-	-
Net Income	-	28.48M	217M	-	-
Pharmaceuticals	7.6M	-	-	-	-
Total Assets	110M	-	-	-	-
Interest Expense	-163K	-	-	-	-
Income Tax Expense	45K	-	-	-	-
CAPEX	-1.34M	-	-	-	-
EBT	-80.46M	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	5.17M	-	-	-	-
Net Income	-80.51M	-	-	-	-
Inter-Segment Elimination	-	-	-	-	-72.51M
Gross Profit	-	-	-	-	-4.04M
EBITDA	-	-	-	-	-279K
Operating Income	-	-	-	-	-279K
Total Assets	-	-	-	598M	187M
Operating Income	-	-	-78.36M	-	-
Net Income	-	-55.96M	-88.99M	-	-
D&A	-	191K	540K	-	-
EBITDA	-	-31.39M	-42.83M	-	-
EBT	-	-56.21M	-91.11M	-	-
Income Tax Expense	-	-250K	-	-	-
Total Assets	-	99.46M	63.11M	-	-

Geographical breakdown of sales (AUD)

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
United States	-	150M	490M	762M	785M
Total Assets	-	5.16M	4.13M	174M	481M
China	-	3.35M	5.29M	-	9.83M
Other Countries	-	2.5M	4.67M	16.01M	9.06M
Total Assets	-	-	-	4.85M	8.24M
Canada	-	-	-	2.54M	-
Total Assets	-	-	-	126M	86.64M
United Kingdom	-	2.04M	1.31M	579K	-
Total Assets	-	-	50.35M	54.64M	37.07M
Belgium	-	564K	458K	546K	-
Total Assets	-	41.17M	77.47M	101M	59.46M
Austria	-	1.48M	-	-	-
Australia	7.6M	149K	1.17M	1.22M	-
Total Assets	110M	31.82M	21.06M	90.99M	102M
Interest Expense	-163K	-	-	-	-
Income Tax Expense	45K	-	-	-	-
D&A	5.17M	-	-	-	-
CAPEX	-1.34M	-	-	-	-
Gross Profit	-	-	-	-	-
Net Income	-80.51M	-	-	-	-
EBT	-80.46M	-	-	-	-